CORRELATION OF C-REACTIVE PROTEIN (CRP), AND INTERLEUKIN-6 (IL-6) WITH HEPCIDIN LEVELS IN PATIENTS WITH ANEMIA OF CHRONIC DISEASE (ACD)

I Putu Arya Giri Prebawa, Ketut Suega

Abstract


Anemia of chronic disease (ACD) or anemia of chronic inflammation is the most common cause of anemia in hospitalized patients. Recent studies revealed that interleukin-6 (IL-6), C-reactive protein (CRP), and Hepcidin play a key role in ACD pathogenesis. This study is an observational study with a crossectional approach that aims to see the relationship between levels of inflammatory marker such as CRP and IL-6 with Hepcidin on the incidence of ACD at Prof Ngoerah Hospital Denpasar. This study involved 92 samples. Descriptive analysis will be presented in the form of tables and narratives for all data obtained in this study. Bivariate analysis was carried out using the Spearman correlation. The mean CRP level of the patients in this study was 89.1 ± 80.1 mg/L which could be categorized as high. The mean Il-6 level of the patients in this study was 91,8±88,4 pg/mL which could be categorized as high and the Hepcidin level in this study was 64.4 ± 49.9 ng/dL. This study shows that inflammation plays a role in increasing levels of Hepcidin which plays a role in the pathogenesis of ACD. This can be seen from the significant positive correlation between Hepcidin levels and IL-6 levels (P=0,00), although there is no correlation between Hepcidin and CRP. Inflammation plays a role in increasing levels of Hepsidin which plays a role in the pathogenesis of ACD.


Keywords


ACD, Hepcidin, CRP, IL-6

Full Text:

PDF

References


Madu AJ, Ughasoro MD. Anaemia of Chronic Disease: An In-Depth Review. Med Princ Pr. 2017;26(1):1–9.

Kasper; Denis L, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.

Poggiali E, Amicis MD, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med. 2014;25(1):12–7.

McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis. 2014;52(2–3):126–33.

Agarwal N, Prchal JT. Anemia of Chronic Disease (Anemia of Inflammation). Karger Publ. 2009;122(2–3):78–82.

Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. BJHaem. 2011;7(11):6–12.

Gaspar BL, Sharma P, Das R. Anemia of chronic disease. Hematology. 2015;20(1):18–25.

Cheng PP, Jiao XY, Wang XH, et al. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med. 2011;11:33–42.

Yacoub MF, Ferwiz HF, Said F. Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases. Hindawi Publ Corp. 2019;8(7):17–22.

Haurani FI. Hepcidin and the anemia of chronic disease. Ann Clin Lab Sci. 2006;36(1):3–6.

Angelo GD. Role of Hepcidin in the pathophysiology and diagnosis of anemia. Blood Res. 2013;48(1):10–5.

Detivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, Ropert M, Jacquelinet S, Courselaud B, Ganz T, Brissot P, Lore´al O. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood. 2005; 106: 746-48.

Tessel E. Galesloot. Serum Hepcidin: reference ranges and biochemical correlates in the general population. BLOOD. 2011; volume 117: number 25.

Kato A, Tsuji T, Luo J, SakaoY, Yasuda H, Hishida A. Association of pro Hepcidin and Hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol . 2008; 28(1):115–21.

Eguchi A, Mochizuki T, Tsukada M, Kataoka K, Hamaguchi, Oguni S, Nitta K,Tsuchiya K. Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients. Int.J. Nephrol. 2012; September 27: 1-7.

Koury MJ. A temporal role for Hepcidin in the anemia of inflammation and chronic disease. The Hematologist. 2012; Nov 01.

Rodríguez-Mortera, R.; Caccavello, R.; Hermo, R.; Garay-Sevilla, M.E.; Gugliucci, A. Higher Hepcidin Levels in Adolescents with Obesity Are Associated with Metabolic Syndrome Dyslipidemia and Visceral Fat. Antioxidants. 2021, 10, 751.

Price EA, Schrier SL. Crosstalk between Erythropoiesis and Iron Metabolism. Hindawi Publ Corp. 2010;5(9):73–9.

Nemeth E, Ganz T. Anemia of Inflammation. Hematol Oncol Clin N Am. 2014;28(4):671–81.




DOI: https://doi.org/10.26618/aimj.v6i2.9984

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 I Putu Arya Giri Prebawa, Ketut Suega

Creative Commons License
Al-Iqra Medical Journal: Jurnal Ilmiah Kedokteran under by Creative Commons Attribution-NoDerivatives 4.0 International License.